Quantcast

Daily Traders Edge

Regeneron and Sanofi Get Favorable Ruling Against Amgen

October 06
13:00 2017

Regeneron and Sanofi Get Favorable Ruling Against AmgenRegeneron Pharmaceuticals(REGN) and partner Sanofi, Inc. (SNY) receives a favorable ruling from the Court of Appeals for the Federal Circuit relating to Praluent.


Related Articles

Newsletter Signup

Sign up for our free newsletter